4-n-Nonylbenzeneboronic acid, 98+%
4-n-Nonylbenzeneboronic acid, 98+%
4-n-Nonylbenzeneboronic acid, 98+%
Thermo Scientific Chemicals

4-n-Nonylbenzeneboronic acid, 98+%

CAS: 256383-45-6 | C15H25BO2 | 248.173 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
1 g
5 g
Catalog number L17753.03
also known as L17753-03
Price (USD)
105.65
Online Exclusive
117.00
Save 11.35 (10%)
Each
Quantity:
1 g
Request bulk or custom format
Price (USD)
105.65
Online Exclusive
117.00
Save 11.35 (10%)
Each
Chemical Identifiers
CAS256383-45-6
IUPAC Name(4-nonylphenyl)boronic acid
Molecular FormulaC15H25BO2
InChI KeyVONVJOGSLHAKOX-UHFFFAOYSA-N
SMILESCCCCCCCCCC1=CC=C(C=C1)B(O)O
View more
SpecificationsSpecification SheetSpecification Sheet
Proton NMRConforms to structure
Assay (HPLC)≥98.0%
Appearance (Color)White
Assay (Aqueous acid-base Titration)≥98.0%
FormCrystals or powder or crystalline powder
4-n-Nonylbenzeneboronic acid is a potent inhibitor of fatty acid amide hydrolase. It is also able to inhibit monoacylglycerol lipase (MAGL), which hydrolyzes 2-arachidonoyl glycerol (2-AG).

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
4-n-Nonylbenzeneboronic acid is a potent inhibitor of fatty acid amide hydrolase. It is also able to inhibit monoacylglycerol lipase (MAGL), which hydrolyzes 2-arachidonoyl glycerol (2-AG).

Solubility
Insoluble in water.

Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Incompatible with oxidizing agents.
RUO – Research Use Only

General References:

  1. Sholto R. McLaren.; Daniel J. Tate.; Owen R. Lozman.; Georg H. Mehl.; Richard J. Bushby. Stabilised columnar mesophases formed by 1 : 1 mixtures of hexaalkoxytriphenylenes with a hexaphenyltriphenylene-based polymer. Mater. Chem. C. 2015, 3 (16), 5754-5763.
  2. amara Delaine.; Vania Bernardes-Génisson.; Annaïk Quémard.; Patricia Constant.; Bernard Meunier.; Jean Bernadou. Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents . European Journal of Medicinal Chemistry. 2010, 45 (10), 4554-4561.